A potential therapy for amyotrophic lateral sclerosis, a fatal neurological disorder, may allow patients to live several months longer than they otherwise would have, according to a study published Friday.
The two-drug combination, dreamed up by two college students, is one of several potential treatments raising the hopes of patients with ALS, also known as Lou Gehrig’s disease.
A Long Island man has died after spending close to 30 years championing a cure for amyotrophic lateral sclerosis (ALS) while also battling the debilitating disease himself, according to Newsday.
Christopher Pendergast died at his home on Wednesday, 28 years after he was diagnosed with ALS, which is also commonly referred to as Lou Gehrig's Disease, his family confirmed to the outlet. He was 71.
The ALS Association Greater San Diego Chapter is hosting its 20th annual Walk to Defeat ALS virtually this Sunday to keep fundraiser participants safe amid the COVID-19 pandemic.
An experimental drug combination lengthens survival for patients with amyotrophic lateral sclerosis (ALS), new research shows. A previous clinical trial found that the two-drug combo -- called AMX0035 -- slowed progression of the neurodegenerative disease over six months.
The ALS Association Greater New York Chapter will host their Lou Gehrig Legacy Gala on Monday, November 9th, at 7:00PM.
The virtual celebration will recognize former Baltimore Orioles shortstop Cal Ripken Jr. and mark the 25th Anniversary of his record-breaking game when he surpassed Lou Gehrig's consecutive game streak.